Direct Oral Anticoagulants - ppt video online download
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Xarelto®(rivaroxaban) Prescriber Guide
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar
What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho,
Xarelto® - Dosing Guide
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve | NEJM
Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study | Scientific Reports
Dose Regimens in Approved Rivaroxaban Indications. 1 | Download Table
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study - Staerk - 2018 - Journal of Internal Medicine - Wiley Online Library
Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events | AAFP
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke
Doses Studied in RCTs of Rivaroxaban and Dabigatran - Prevention and Treatment of Venous Thromboembolism - Advances in Anticoagulation for Venous Thromboembolism
Pharmaceutics | Free Full-Text | Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article
The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE
